Video

The Role of Potassium-Binding Agents in Treating Hyperkalemia

Conference|ASN Kidney Week - American Society of Nephrology Kidney Week

Dr. Cary Boyd-Shiwarski explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Pharmacy Times spoke to Dr. Cary Boyd-Shiwarski about her session at the ASN 2021 conference titled "Mechanisms of Potassium Handling in CKD."

Boyd explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Monoclonal antibodies are used to treat lung cancer. They are created in a lab and designed to target specific proteins on cancer cells, stopping them from growing and dividing.
Gene therapy in lung cancer (LC) - isometric view 3d illustration
Related Content
Man in red shirt holding stomach - Image credit: Mladen | stock.adobe.com
September 15th 2025

Study Finds Overweight Status May Aid Older Adults in Surgery Recovery

Kennedy Ferruggia, Assistant Editor
Pharmacy focus oncology Edition, radon and lung cancer
September 15th 2025

A Silent Killer: Unmasking Radon’s Link to Lung Cancer

Alexandra Gerlach, Associate Editor
White pill bottle with "doctor recommended" label on gray background | Image Credit: SERHII | stock.adobe.com
September 15th 2025

FDA Cracks Down on Deceptive Prescription Drug Advertising

Danielle Valletti, Assistant Editor
Sifting Through Discordant Data From ESC 2025
September 15th 2025

Sifting Through Discordant Data From ESC 2025

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Abstract luminous DNA molecule. Genetic and gene manipulation concept. Cut of replacing part of a DNA molecule. Medicine. Innovative in science. Medical science and biotechnology.
September 15th 2025

Addressing Adverse Outcomes and Enhancing Patient Care in Gene Therapy

Luke Halpern, Assistant Editor
Panel of health care professionals -- Image credit: Africa Studio | stock.adobe.com
September 15th 2025

Decoding Most Favored Nation: Expert Insights on the Impacts to Patients, Pharma, and Innovation

Brian Corvino Neal Masia, PhD Ali Pashazadeh George Van Antwerp, MBA Ned Milenkovich, PharmD, JD Gillian McGovern, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.